메뉴 건너뛰기




Volumn 68, Issue 12, 2013, Pages 2859-2865

A new regimen for continuous infusion of vancomycin during continuous renal replacement therapy

Author keywords

Loading dose; Pharmacokinetics; Sepsis

Indexed keywords

VANCOMYCIN;

EID: 84887515516     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt261     Document Type: Article
Times cited : (46)

References (39)
  • 1
    • 84859945784 scopus 로고    scopus 로고
    • Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia dueto methicillin-resistant Staphylococcus aureus.
    • Haque NZ, Arshad S, Peyrani P et al. Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia dueto methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2012;50: 1640-4.
    • (2012) J Clin Microbiol , vol.50 , pp. 1640-1644
    • Haque, N.Z.1    Arshad, S.2    Peyrani, P.3
  • 2
    • 80052262626 scopus 로고    scopus 로고
    • Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study
    • Hanberger H, Walther S, Leone M et al. Increased mortality associated with methicillin-resistant Staphylococcus aureus (MRSA) infection in the intensive care unit: results from the EPIC II study. Int J Antimicrob Agents 2011; 38: 331-5.
    • (2011) Int J Antimicrob Agents , vol.38 , pp. 331-335
    • Hanberger, H.1    Walther, S.2    Leone, M.3
  • 3
    • 67651083250 scopus 로고    scopus 로고
    • Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
    • Rybak MJ, Lomaestro BM, Rotschafer JC et al. Vancomycin therapeutic guidelines: a summary of consensus recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists. Clin Infect Dis 2009; 49: 325-37.
    • (2009) Clin Infect Dis , vol.49 , pp. 325-337
    • Rybak, M.J.1    Lomaestro, B.M.2    Rotschafer, J.C.3
  • 4
    • 84857611419 scopus 로고    scopus 로고
    • The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis
    • van Hal SJ, Lodise TP, Paterson DL. The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 2012; 54: 755-71.
    • (2012) Clin Infect Dis , vol.54 , pp. 755-771
    • van Hal, S.J.1    Lodise, T.P.2    Paterson, D.L.3
  • 5
    • 70349085778 scopus 로고    scopus 로고
    • Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillinresistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia
    • Harigaya Y, Bulitta JB, Forrest A et al. Pharmacodynamics of vancomycin at simulated epithelial lining fluid concentrations against methicillinresistant Staphylococcus aureus (MRSA): implications for dosing in MRSA pneumonia. Antimicrob Agents Chemother 2009; 53: 3894-901.
    • (2009) Antimicrob Agents Chemother , vol.53 , pp. 3894-3901
    • Harigaya, Y.1    Bulitta, J.B.2    Forrest, A.3
  • 6
    • 44249096170 scopus 로고    scopus 로고
    • Therapeutic drug monitoring of vancomycin in severe sepsis and septic shock
    • Vázquez M, Fagiolino P, Boronat A et al. Therapeutic drug monitoring of vancomycin in severe sepsis and septic shock. Int J Clin Pharmacol Ther 2008; 46: 140-5.
    • (2008) Int J Clin Pharmacol Ther , vol.46 , pp. 140-145
    • Vázquez, M.1    Fagiolino, P.2    Boronat, A.3
  • 7
    • 62849095029 scopus 로고    scopus 로고
    • Pharmacokinetic issues for antibiotics in the critically ill patient
    • Roberts JA, Lipman J. Pharmacokinetic issues for antibiotics in the critically ill patient. Crit Care Med 2009; 37: 840-51.
    • (2009) Crit Care Med , vol.37 , pp. 840-851
    • Roberts, J.A.1    Lipman, J.2
  • 8
    • 84859420783 scopus 로고    scopus 로고
    • Augmentedrenal clearance in septic patients and implications for vancomycin optimisation
    • Baptista JP, Sousa E, Martins PJ. et al. Augmentedrenal clearance in septic patients and implications for vancomycin optimisation. Int J Antimicrob Agents 2012; 39: 420-3.
    • (2012) Int J Antimicrob Agents , vol.39 , pp. 420-423
    • Baptista, J.P.1    Sousa, E.2    Martins, P.J.3
  • 9
    • 84858285471 scopus 로고    scopus 로고
    • Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients
    • Ocampos-Martinez E, Penaccini L, Scolletta S et al. Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients. Int J Antimicrob Agents 2012; 39: 332-7.
    • (2012) Int J Antimicrob Agents , vol.39 , pp. 332-337
    • Ocampos-Martinez, E.1    Penaccini, L.2    Scolletta, S.3
  • 10
    • 0034863918 scopus 로고    scopus 로고
    • Continuous renal replacement therapy in critically ill patients
    • Ronco C, Bellomo R, Ricci Z. Continuous renal replacement therapy in critically ill patients. Nephrol Dial Transplant 2001; 16: 67-72.
    • (2001) Nephrol Dial Transplant , vol.16 , pp. 67-72
    • Ronco, C.1    Bellomo, R.2    Ricci, Z.3
  • 11
    • 36248946604 scopus 로고    scopus 로고
    • Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy
    • Pea F, Viale P, Pavan F. et al. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Clin Pharmacokinet 2007; 46: 997-1038.
    • (2007) Clin Pharmacokinet , vol.46 , pp. 997-1038
    • Pea, F.1    Viale, P.2    Pavan, F.3
  • 12
    • 79955772659 scopus 로고    scopus 로고
    • Antibiotic dosing in multiple organ dysfunction syndrome
    • Ulldemolins M, Roberts JA, Lipman J. et al. Antibiotic dosing in multiple organ dysfunction syndrome. Chest 2011; 139: 1210-20.
    • (2011) Chest , vol.139 , pp. 1210-1220
    • Ulldemolins, M.1    Roberts, J.A.2    Lipman, J.3
  • 13
    • 84861489948 scopus 로고    scopus 로고
    • Vancomycin concentrations are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD)
    • Wilson FP, Berns JS. Vancomycin concentrations are frequently subtherapeutic during continuous venovenous hemodialysis (CVVHD). Clin Nephrol 2012; 77: 329-31.
    • (2012) Clin Nephrol , vol.77 , pp. 329-331
    • Wilson, F.P.1    Berns, J.S.2
  • 14
    • 4444251438 scopus 로고    scopus 로고
    • Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration
    • DelDot ME, Lipman J, Tett SE. Vancomycin pharmacokinetics in critically ill patients receiving continuous venovenous haemodiafiltration. Br J Clin Pharmacol 2004; 58: 259-68.
    • (2004) Br J Clin Pharmacol , vol.58 , pp. 259-268
    • DelDot, M.E.1    Lipman, J.2    Tett, S.E.3
  • 15
    • 79959732600 scopus 로고    scopus 로고
    • Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients
    • Chaijamorn W, Jitsurong A, Wiwattanawongsa K. et al. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients. Int J Antimicrob Agents 2011; 38: 152-6.
    • (2011) Int J Antimicrob Agents , vol.38 , pp. 152-156
    • Chaijamorn, W.1    Jitsurong, A.2    Wiwattanawongsa, K.3
  • 16
    • 0032694744 scopus 로고    scopus 로고
    • Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients
    • Boereboom FT, Ververs FF, Blankestijn PJ. et al. Vancomycin clearance during continuous venovenous haemofiltration in critically ill patients. Intensive Care Med 1999; 25: 1100-4.
    • (1999) Intensive Care Med , vol.25 , pp. 1100-1104
    • Boereboom, F.T.1    Ververs, F.F.2    Blankestijn, P.J.3
  • 17
    • 0031749303 scopus 로고    scopus 로고
    • Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis
    • Joy MS, Matzke GR, Frye RF. et al. Determinants of vancomycin clearance by continuous venovenous hemofiltration and continuous venovenous hemodialysis. Am J Kidney Dis 1998; 31: 1019-27.
    • (1998) Am J Kidney Dis , vol.31 , pp. 1019-1027
    • Joy, M.S.1    Matzke, G.R.2    Frye, R.F.3
  • 18
    • 17944367778 scopus 로고    scopus 로고
    • Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study
    • Wysocki M, Delatour F, Faurisson F. et al. Continuous versus intermittent infusion of vancomycin in severe staphylococcal infections: prospective multicenter randomized study. Antimicrob Agents Chemother 2001, 45: 2460-7.
    • (2001) Antimicrob Agents Chemother , vol.45 , pp. 2460-2467
    • Wysocki, M.1    Delatour, F.2    Faurisson, F.3
  • 19
    • 84859170733 scopus 로고    scopus 로고
    • Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis
    • Cataldo MA, Tacconelli E, Grilli E. et al. Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis. J Antimicrob Chemother 2012; 67: 17-24.
    • (2012) J Antimicrob Chemother , vol.67 , pp. 17-24
    • Cataldo, M.A.1    Tacconelli, E.2    Grilli, E.3
  • 20
    • 84864237868 scopus 로고    scopus 로고
    • Continuous infusion of antibiotics in the critically ill: the new holy grail for b-lactams and vancomycin?
    • Van Herendael B, Jeurissen A, Tulkens PM. et al. Continuous infusion of antibiotics in the critically ill: the new holy grail for b-lactams and vancomycin? Ann Intensive Care 2012; 2: 22.
    • (2012) Ann Intensive Care , vol.2 , pp. 22
    • Van Herendael, B.1    Jeurissen, A.2    Tulkens, P.M.3
  • 21
    • 84872901678 scopus 로고    scopus 로고
    • Continuous infusion of vancomycin in septic patients on continuous renal replacement therapy
    • Covajes C, Scoletta S, Penaccini L. et al. Continuous infusion of vancomycin in septic patients on continuous renal replacement therapy. Int J Antimicrob Agents, 2013; 41: 262-6.
    • (2013) Int J Antimicrob Agents , vol.41 , pp. 262-266
    • Covajes, C.1    Scoletta, S.2    Penaccini, L.3
  • 22
    • 79956324640 scopus 로고    scopus 로고
    • Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens
    • Roberts JA, Taccone FS, Udy AA. et al. Vancomycin dosing in critically ill patients: robust methods for improved continuous-infusion regimens. Antimicrob Agents Chemother 2011; 55: 2704-9.
    • (2011) Antimicrob Agents Chemother , vol.55 , pp. 2704-2709
    • Roberts, J.A.1    Taccone, F.S.2    Udy, A.A.3
  • 23
    • 0022256529 scopus 로고
    • APACHE II: a severity of disease classification system
    • KnausWA, Draper EA,Wagner DP. et al. APACHE II: a severity of disease classification system. Crit Care Med 1985; 13: 818-29.
    • (1985) Crit Care Med , vol.13 , pp. 818-829
    • Knaus, W.A.1    Draper, E.A.2    Wagner, D.P.3
  • 24
    • 0030015661 scopus 로고    scopus 로고
    • The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine
    • Vincent JL, Moreno R, Takala J. et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-10.
    • (1996) Intensive Care Med , vol.22 , pp. 707-710
    • Vincent, J.L.1    Moreno, R.2    Takala, J.3
  • 26
    • 0033120135 scopus 로고    scopus 로고
    • A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models
    • Parke J, Holford NH, Charles BG. A procedure for generating bootstrap samples for the validation of nonlinear mixed-effects population models. Comput Methods Programs Biomed 1999; 59: 119-29.
    • (1999) Comput Methods Programs Biomed , vol.59 , pp. 119-129
    • Parke, J.1    Holford, N.H.2    Charles, B.G.3
  • 27
    • 0029397906 scopus 로고
    • Antimicrobial prescribing in patients on haemofiltration
    • Cotterill S. Antimicrobial prescribing in patients on haemofiltration. J Antimicrob Chemother 1995; 36: 773-80.
    • (1995) J Antimicrob Chemother , vol.36 , pp. 773-780
    • Cotterill, S.1
  • 28
    • 84055213987 scopus 로고    scopus 로고
    • Initial vancomycin dosing recommendations for critically ill patients undergoing continuous venovenous hemodialysis
    • van de Vijsel LM, Walker SA, Walker SE. et al. Initial vancomycin dosing recommendations for critically ill patients undergoing continuous venovenous hemodialysis. Can J Hosp Pharm 2010; 63: 196-206.
    • (2010) Can J Hosp Pharm , vol.63 , pp. 196-206
    • van de Vijsel, L.M.1    Walker, S.A.2    Walker, S.E.3
  • 30
    • 84861549960 scopus 로고    scopus 로고
    • Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin
    • Shiraishi Y, Okajima M, Sai Y. et al. Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin. Anaesth Intensive Care 2012; 40: 442-9.
    • (2012) Anaesth Intensive Care , vol.40 , pp. 442-449
    • Shiraishi, Y.1    Okajima, M.2    Sai, Y.3
  • 31
    • 70350619885 scopus 로고    scopus 로고
    • Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections
    • Berthoin K, Ampe E, Tulkens PM. et al. Correlation between free and total vancomycin serum concentrations in patients treated for Gram-positive infections. Int J Antimicrob Agents 2009; 34: 555-60.
    • (2009) Int J Antimicrob Agents , vol.34 , pp. 555-560
    • Berthoin, K.1    Ampe, E.2    Tulkens, P.M.3
  • 32
    • 79952105014 scopus 로고    scopus 로고
    • Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy
    • Pasko DA, Churchwell MD, Salama NN. et al. Longitudinal hemodiafilter performance in modeled continuous renal replacement therapy. Blood Purif 2011; 32: 82-8.
    • (2011) Blood Purif , vol.32 , pp. 82-88
    • Pasko, D.A.1    Churchwell, M.D.2    Salama, N.N.3
  • 33
    • 34147129239 scopus 로고    scopus 로고
    • Ultrafiltration rate as a dose surrogate in pre-dilution hemofiltration
    • Huang Z, Letteri JJ, Clark WR et al. Ultrafiltration rate as a dose surrogate in pre-dilution hemofiltration. Int J Artif Organs 2007; 30: 124-32.
    • (2007) Int J Artif Organs , vol.30 , pp. 124-132
    • Huang, Z.1    Letteri, J.J.2    Clark, W.R.3
  • 35
    • 0027243672 scopus 로고
    • Drug dosage in patients during continuous renal replacement therapy: pharmacokinetic and therapeutic considerations
    • Reetze-Bonorden P, Bohler J, Keller E. Drug dosage in patients during continuous renal replacement therapy: pharmacokinetic and therapeutic considerations. Clin Pharmacokinet 1993; 24: 362-79.
    • (1993) Clin Pharmacokinet , vol.24 , pp. 362-379
    • Reetze-Bonorden, P.1    Bohler, J.2    Keller, E.3
  • 36
    • 0035654136 scopus 로고    scopus 로고
    • Elimination of the piperacillin/ tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure
    • Valtonen M, Tiula E, Takkunen O et al. Elimination of the piperacillin/ tazobactam combination during continuous venovenous haemofiltration and haemodiafiltration in patients with acute renal failure. J Antimicrob Chemother 2001; 48: 881-5.
    • (2001) J Antimicrob Chemother , vol.48 , pp. 881-885
    • Valtonen, M.1    Tiula, E.2    Takkunen, O.3
  • 37
    • 84860229974 scopus 로고    scopus 로고
    • Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study
    • Roberts DM, Roberts JA, Roberts MS et al. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Crit Care Med 2012; 40: 1523-8.
    • (2012) Crit Care Med , vol.40 , pp. 1523-1528
    • Roberts, D.M.1    Roberts, J.A.2    Roberts, M.S.3
  • 38
    • 7444254040 scopus 로고    scopus 로고
    • Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratorytract infections
    • Moise-Broder PA, Forrest A, Birmingham MC et al. Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratorytract infections. ClinPharmacokinet2004;43:925-42.
    • (2004) ClinPharmacokinet , vol.43 , pp. 925-942
    • Moise-Broder, P.A.1    Forrest, A.2    Birmingham, M.C.3
  • 39
    • 84872925796 scopus 로고    scopus 로고
    • Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock
    • Zelenitsky S, Rubinstein E, Ariano R et al. Vancomycin pharmacodynamics and survival in patients with methicillin-resistant Staphylococcus aureus-associated septic shock. Int J Antimicrob Agents 2013; 41: 255-60.
    • (2013) Int J Antimicrob Agents , vol.41 , pp. 255-260
    • Zelenitsky, S.1    Rubinstein, E.2    Ariano, R.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.